Thomas Björk - Concepedia

Author

Thomas Björk

Also Known As

Bj\"ork, Thomas, Björk, Thomas, T Björk, T. Bjork, T. Björk, THOMAS BJÖRK, THOMAS BJöRK, Thomas Bjork, Thomas Björk, Thomas BjÖrk

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Lund University Malmö University Memorial Sloan Kettering Cancer Center University of Turku Skåne University Hospital

About

Thomas Björk is an author at Lund University specializing in urology, medicine, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	592
2	Health Sciences	2	2	195
3	Cell Biology	2	2	214
4	Biostatistics	1	1	185
5	Nephrology	1	1	40

Thomas Björk

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types José Baselga, Danny Rischin, Malcolm Ranson, Journal of Clinical Oncology	2002	829
Serum Prostate Specific Antigen Complexed to<i>α</i>1-Antichymotrypsin as an Indicator of Prostate Cancer Anders Christensson, Thomas Björk, Olle Nilsson, The Journal of Urology	1993	648
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study Andrew J. Vickers, David Ulmert, Daniel D. Sjoberg, BMJ	2013	278
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study Andrew J. Vickers, A. Cronin, Thomas Björk, BMJ	2010	237
Long-Term Prediction of Prostate Cancer Up to 25 Years Before Diagnosis of Prostate Cancer Using Prostate Kallikreins Measured at Age 44 to 50 Years Hans Lilja, David Ulmert, Thomas Björk, Journal of Clinical Oncology	2007	202
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index David Ulmert, Reza Kaboteh, Josef J. Fox, European Urology UrologyMedical ImagingCancer DetectionMedicineNovel Automated Platform	2012	185
Alpha1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatc hyperplasia Thomas Björk, Anders Bjartell, Per‐Anders Abrahamsson, Urology UrologyPerineural InvasionGenitourinary CancerBenign Prostatc HyperplasiaBenign Prostatic Hyperplasia	1994	130
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study David Ulmert, Angel M. Cronin, Thomas Björk, BMC Medicine	2008	120
Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population David Ulmert, Angel M. Serio, M. Frank O’Brien, Journal of Clinical Oncology	2008	103
DISCRIMINATION OF MEN WITH PROSTATE CANCER FROM THOSE WITH BENIGN DISEASE BY MEASUREMENTS OF HUMAN GLANDULAR KALLIKREIN 2 (HK2) IN SERUM Charlotte Becker, Timo Piironen, Kim Pettersson, The Journal of Urology	2000	90

Page 1